Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 9Pancreatic Neoplasms 8Rectal Neoplasms 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Colonic Neoplasms 3Adenocarcinoma Of Esophagus 3Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Neoplasm Metastasis 2Clinical Stage I Gastric Cancer AJCC v8 2Cholangiocarcinoma 2Appendiceal Neoplasms 2Anus Neoplasms 2Uterine Neoplasms 1Tongue Neoplasms 1Sinonasal undifferentiated carcinoma 1Salivary Gland Neoplasms 1Peritoneal Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1PRETEXT I Hepatoblastoma 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Metastatic Small Intestinal Adenocarcinoma 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1

Interventions

Radiotherapy 2Docetaxel 2Cisplatin 2Carboplatin 2toripalimab 1enasidenib 1dehydroftorafur 1Radiation 1Platinum 1Fluorouracil 1Chemoradiotherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × dehydroftorafur × 1 year × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡